SCOPUS 정보 검색 플랫폼

Annals of Oncology

Volumn 12, Issue 8, 2001, Pages 1033-1035

Are European cancer patients getting a fair deal?

(1) McVie, J G a

a IMPERIAL CANCER RESEARCH FUND (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CAPECITABINE; CYTOTOXIC AGENT; LOPINAVIR; NEW DRUG; RITONAVIR; TRASTUZUMAB;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL PROTOCOL; COLON CANCER; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG SAFETY; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; EDITORIAL; EUROPE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL EXPERT; PEER REVIEW; PRIORITY JOURNAL; QUALITY CONTROL; RISK BENEFIT ANALYSIS; UNITED STATES;

ANTINEOPLASTIC AGENTS; DRUG APPROVAL; EUROPE; EUROPEAN UNION; HUMANS; NEOPLASMS; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0034824465 PISSN: 09237534 EISSN: None Source Type: Journal
DOI: 10.1023/A:1011655500247 Document Type: Editorial

Times cited : (3)

References (19)

1
- 0003717345
- Andersen Consulting, Evaluation of the operation of Community Procedures for the Authorisation of Medicinal Products (available at.
- McKenna, C.¹

2
- 0003620556
- European Medicines Evaluation Agency. EMEA Status Report, April (available at).
- (2001)

3
- 0003620558
- Centre for Drug Evaluation and Research. CDER Report to the Nation: Improving Public Health Through Human Drugs. US Department of Health and Human Services, Food and Drug Administration (available at).
- (1999)

4
- 0003711754
- European Medicines Evaluation Agency. European Public Assessment Report for Herceptin, August (available at).
- (2000)

5
- 0003607961
- U.S. Department of Health and Human Services. HHS News: New monoclonal antibody approved for advanced breast cancer, 25 September (available at).
- (1998)

6
- 0003565451
- European Medicines Evaluation Agency. European Public Assessment Report for Xeloda, February (available at).
- (2001)

7
- 0003566458
- U.S. Food and Drug Administration. FDA Talk Paper: FDA approves Xeloda for Breast Cancer, 30 April (available at).
- (1998)

8
- 0003639086
- European Medicines Evaluation Agency. EMEA 6th General Report, London: EMEA (available at).
- (2000)

9
- 0003711756
- European Medicines Evaluation Agency. Accelerated evaluation of products indicated for serious diseases. CPMP/495/96.FINAL. London: EMEA (available at).
- (1996)

10
- 0003719808
- European Medicines Evaluation Agency. European Public Assessment Report for Norvir, (available at).
- (1996)

11
- 0003639088
- U.S. Food and Drug Administration. NDAs Approved under subpart H, March (available at).
- (2001)

12
- 0003562265
- European Medicines Evaluation Agency. European Public Assessment Report for Kaletra, March (available at).
- (2001)

13
- 0003717347
- European Commission, Enterprise Directorate-General. Review of pharmaceutical legislation: Discussion document (final version), 22 January (available at).
- (2001)

14
- 0003639090
- U.S. Food and Drug Administration. Reinventing the regulation of cancer drugs: accelerating approval and expanding access. March.
- (1996)

15
- 0003566460
- European Union. Council Directive 75/318/EEC (annex 4G).
- (1975) Official J Eur Commun , vol.L , Issue.147

16
- 0003566462
- European Medicines Evaluation Agency. Applications in the centralised procedure 1995 to July 1999 - an analysis of outcomes. CPMP/602/00. London: EMEA.
- (2000)

17
- 0003639092
- European Medicines Evaluation Agency. Note for guidance on evaluation of anticancer medicinal products in man. CPMP/EWP/205/95 rev. 1 (available at).

18
- 0003630997
- U.S. Food and Drug Administration. Cancer Liaison Program. March (available at).
- (2001)

19
- 0003566464
- European Medicines Evaluation Agency. Report on meeting with the European AIDS Treatment Group held on 14 December 1999. Annex III to CPMP December Press Release. CPMP/3323/99 (available at).
- (1999)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.